Science inspired by nature
With our elegant next generation chimeric antigen receptor T (CAR-T) and NK (CAR-NK) platforms and one of the largest portfolios of CAR-T and CAR-NK assets in the world, we have a simple goal: to become the dominant cell therapy company in the world.